PMC:7228307 / 9977-10185
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T174 | 90-92 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
T175 | 93-95 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | Rs |
T176 | 107-108 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T47 | 61-70 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T48 | 121-129 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 0-208 | Sentence | denotes | In the context of normal immune physiology, opsonized target molecules can engage various FcγRs and induce a spectrum of effector responses which can be harnessed by many therapeutic mAbs (Figure 1, Table 1). |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T55 | 0-208 | Sentence | denotes | In the context of normal immune physiology, opsonized target molecules can engage various FcγRs and induce a spectrum of effector responses which can be harnessed by many therapeutic mAbs (Figure 1, Table 1). |